68428-552 : Pancreatinum 30 [Hp_c]/1 Oral Pellet
NDC: | 68428-552 |
Labeler: | Washington Homeopathic Products |
Product Type: | Human OTC Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Pellet |
Rev. Date: |
NDC Package Codes:
- 68428-552-03: 75 PELLET IN 1 VIAL, GLASS (68428‑552‑03)
- 68428-552-05: 150 PELLET IN 1 VIAL, GLASS (68428‑552‑05)
- 68428-552-06: 1200 PELLET IN 1 BOTTLE, GLASS (68428‑552‑06)
- 68428-552-11: 300 PELLET IN 1 BOTTLE, GLASS (68428‑552‑11)
- 68428-552-12: 600 PELLET IN 1 BOTTLE, GLASS (68428‑552‑12)
Active Ingredients:
- Pancrelipase
Dosage Strength:
- 30 [hp_C]/1
Related Products:
Based on records with the same trade name.- 71919-518 Pancreatinum 30 [Hp_c]/Ml Oral Liquid by Washington Homeopathic Products
- 62106-0287 Pancreatinum 4 [Hp_c]/30ml Oral Liquid by Seroyal USA
- 62106-7110 Pancreatinum 3 [hp_x]/1 Oral Granule by Seroyal USA
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 68428-551Next: 68428-553 >
Related Discussions:
Pancrelipase shortage?
I went to pick up my husband's pancrelipase and the pharmacy said it was discontinued by the manufacturer. Is this t... 7 replies
I went to pick up my husband's pancrelipase and the pharmacy said it was discontinued by the manufacturer. Is this t... 7 replies
Pancrelipase
How much Pancrelipase is needed for pancreatic cancer survivors of long term ? ## What has your doctor advised? There ar... 1 reply
How much Pancrelipase is needed for pancreatic cancer survivors of long term ? ## What has your doctor advised? There ar... 1 reply
pancrelipase capsules
side effects how it should be taken and with what?...
side effects how it should be taken and with what?...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.